Geode Capital Management, LLC

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-13
Total Holdings
8,518
Total Value
1271990368173
Accession Number
0001214717-25-000006
Form Type
13F-HR
Manager Name
Geode Capital Management, LLC
Data Enrichment
94% identified
7,969 identified549 unidentified

Holdings

8,518 positions
Manager:
Search and click to pin securities to the top
Page 164 of 224
Jasper Therapeutics, Inc.
Shares:
263684(+2.3%)
Value:
$1.1B(-79.4%)
Genasys Inc.
Shares:
499175(+2.8%)
Value:
$1.1B(-10.3%)
Seres Therapeutics, Inc.
Shares:
1618772(+7.2%)
Value:
$1.1B(-9.7%)
Smart Sand, Inc.
Shares:
437538(+1.0%)
Value:
$1.1B(+16.2%)
AirJoule Technologies Corp.
Shares:
244950(+3.6%)
Value:
$1.1B(-40.0%)
MainStreet Bancshares, Inc.
Shares:
67213(+5.7%)
Value:
$1.1B(-2.4%)
Inozyme Pharma, Inc.
Shares:
1230765(+4.3%)
Value:
$1.1B(-65.7%)
M-tron Industries, Inc.
Shares:
25126(+5.4%)
Value:
$1.1B(-3.0%)
FRIEDMAN INDUSTRIES INC
Shares:
74742(+5.2%)
Value:
$1.1B(+2.4%)
MAMMOTH ENERGY SERVICES, INC.
Shares:
545164(+1.4%)
Value:
$1.1B(-31.0%)
Tonix Pharmaceuticals Holding Corp.
Shares:
62037
Value:
$1.1B
Taboola.com Ltd.
Shares:
375717(+30.4%)
Value:
$1.1B(+5.4%)
Immunocore Holdings plc
Shares:
37124(+4.6%)
Value:
$1.1B(+5.2%)
Alto Ingredients, Inc.
Shares:
963913(+7.8%)
Value:
$1.1B(-21.2%)
91854V206
Shares:
204063(+4.1%)
Value:
$1.1B(+14.3%)
U.S. GOLD CORP.
Shares:
119936(+14.2%)
Value:
$1.1B(+69.4%)
Kyverna Therapeutics, Inc.
Shares:
563974(+4.5%)
Value:
$1.1B(-46.1%)
ATS Corp /ATS
Shares:
43250(+5.3%)
Value:
$1.1B(-13.9%)
Pyxis Oncology, Inc.
Shares:
1109098(+2.5%)
Value:
$1.1B(-35.6%)
Waldencast plc
Shares:
361661(+0.8%)
Value:
$1.1B(-24.8%)